The four new codes, with their short description, are:
- Q2041 — Wilate injection
- Q2042 — Hydroxyprogesterone caproate
- Q2043 — Sipuleucel-T auto CD54+
- Q2044 — Belimumab injection
The new codes have an MPFSDB status indicator of E.
CMS also announced it will no longer reimburse for J7184 (Wilate injection) effective for claims with dates of service on or after July 1.
View the CMS transmittal (2207) announcing the HCPCS code changes (pdf).
Related Articles on Coding:
Medicare Designates Four New K Codes for Billing Suction Pumps and Surgical Dressings
ICD-10 Straight Talk: Overview
Drug Code Changes Included in July HCPCS Level II Updates
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.